Zobrazeno 1 - 2
of 2
pro vyhledávání: '"C. A. Bochacki"'
Autor:
Thomas Kaley, C. A. Bochacki, Brian M. Alexander, Stephanie E. Weiss, Eudocia C. Quant, S. D. Hallisey, J. Drappatz, Mary Gerard, Patrick Y. Wen, Rameen Beroukhim, Alona Muzikansky, Katrina H. Smith, C. Sceppa, T. Mikkelsen, Eric T. Wong, Andrew B. Lassman, David Schiff, Andrew D. Norden, Tracy T. Batchelor
Publikováno v:
Journal of Clinical Oncology. 29:2069-2069
2069 Background: EGFR and VEGFR signaling have been implicated in the development and growth of GBM. Simultaneous inhibition of both pathways may be more effective than inhibiting a single pathway....
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::029d8e63ceba9a1e18aaacd830c50fe6
https://doi.org/10.1200/jco.2011.29.15_suppl.2069
https://doi.org/10.1200/jco.2011.29.15_suppl.2069
Autor:
Sandra Ruland, A. S. Ciampa, Tracy T. Batchelor, J. Drappatz, Samantha Hammond, Patrick Y. Wen, Myrna R. Rosenfeld, K. Griffin, Rameen Beroukhim, Debra LaFrankie, Eudocia C. Quant, Camilo E. Fadul, C. A. Bochacki, Lisa Doherty, G. J. Lesser, Andrew D. Norden, Alona Muzikansky, C. Sceppa, Mary Gerard
Publikováno v:
Journal of Clinical Oncology. 29:2038-2038
2038 Background: Most GBM patients relapse within 1 year from diagnosis. Among patients who progress on standard temozolomide, the optimal therapy is unknown. Resistance to temozolomide is partiall...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bb0216fb98b0a20ea37757711569331
https://doi.org/10.1200/jco.2011.29.15_suppl.2038
https://doi.org/10.1200/jco.2011.29.15_suppl.2038